Liver Cirrhosis
📧 Sign up to get email alerts when something new happens for Liver Cirrhosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Health Literacy and Self-efficacy Expectations in Patients With Alcohol-related Liver Cirrhosis
A clinical trial from Hannover Medical School is recruiting to study health literacy and self-efficacy in patients with alcohol-related live…
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis [NA]
A completed clinical trial comparing how five substances — caffeine, warfarin, omeprazole, metoprolol, and midazolam — are processed in heal…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: ELECTRICAL STIMULATION AND EXERCISE FOR MUSCLE LOSS IN CIRRHOSIS PATIENTS [NA]
A clinical trial update describes a study on electrical stimulation and exercise to combat muscle loss in patients with liver cirrhosis, wit…
-
FDA approval · 2025-09-08FDA Approved: FUROSEMIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for furosemide from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., updating/expandin…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Risk Assessment for HBV-Related Liver Cancer
A recruiting clinical trial studying risk assessment for HBV-related liver cancer in patients with HBV-related liver cirrhosis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics [Phase 1]
Phase 1 clinical trial update for PHIN-214 assessing single and multiple dose escalation in adults with liver cirrhosis (Child-Pugh A and B)…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes
Clinical trial assessing the prevalence of nonalcoholic fatty liver disease and advanced liver fibrosis in patients with Type 1 diabetes. Th…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: The Diagnostic Value of Subharmonic Imaging Technology Combined With Liver Stiffness and Platelet Count for High-risk Esophageal and Gastric Varices in Patients With Liver Cirrhosis [NA]
A clinical trial evaluating whether subharmonic imaging combined with liver stiffness and platelet count can help identify high-risk esophag…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Blood Collection Biorepository for Liver Disease Research
SUNY Buffalo is conducting a blood collection biorepository for liver disease research, currently recruiting participants to provide samples…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE) [NA]
A clinical trial evaluating human albumin infusion for patients with liver cirrhosis and overt hepatic encephalopathy is currently recruitin…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Feasibility and Safety Evaluation of Endoscopic Treatment of Esophagogastric Varices in Cirrhosis on the Day-care Unit
This entry describes a clinical trial registering a study to evaluate the feasibility and safety of endoscopic treatment of esophagogastric …
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study) [Phase 2]
The ZEAL Phase 2 trial evaluating the combination of Zibotentan and Dapagliflozin for liver cirrhosis has been terminated.
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Evaluation of Non-Invasive Tests for Metabolic Liver Disease
This clinical trial registry entry describes ongoing evaluation of non-invasive tests for metabolic liver disease, with recruitment currentl…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical Resection [NA]
This clinical trial is evaluating CT-guided localization for micro hepatocellular carcinoma before surgical resection. The study is currentl…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: ProspEXPO : Study of the Associations Between Hepatocellular Carcinoma and Chemical and Psychosocial Environmental EXPOsome [NA]
A clinical trial called ProspEXPO investigates associations between hepatocellular carcinoma and chemical and psychosocial environmental exp…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Portal Inflow Modulation Prior to Liver Transplantation in Patients With Increased Risk of Intraoperative Blood Loss [NA]
Clinical trial evaluating portal inflow modulation before liver transplantation in patients with liver cirrhosis and portal hypertension; cu…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Remedial Mechanism of Simvastatin and Ursodeoxycholic Acid in Liver Cirrhosis: Crosstalk of Bile Secretion, Gut Microbiome, and Host Immune Response [NA]
A clinical trial at Chang Gung Memorial Hospital is evaluating the remedial effects of simvastatin and ursodeoxycholic acid in liver cirrhos…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis
A recruiting clinical trial evaluating new prognostic biomarkers in patients with liver cirrhosis, focusing on the decompensated stage.
-
CLINICAL_TRIALS other · 2025-08-06Clinical Trial Update: Acute Portal Pressure Reduction by Metformin and Carvedilol Compared to Carvedilol Alone in Cirrhosis. [NA]
A clinical trial update shows ongoing recruitment for a study evaluating acute portal pressure reduction using metformin plus carvedilol ver…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Predictors of HCC in Post-HCV Cirrhotic Patients After SVR
This clinical trial aims to identify predictors of hepatocellular carcinoma in patients with HCV-related cirrhosis who achieved sustained vi…
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes
A completed Indian clinical trial investigates whether combining gene variants can improve risk prediction for metabolic dysfunction-associa…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: PPIs and In-Hospital Morbidity in Acute Variceal Bleeding With Chronic Liver Disease [Phase 2]
Phase 2 clinical trial evaluating whether proton pump inhibitors reduce in-hospital morbidity in patients with acute variceal bleeding and c…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: A-TANGO Phase 2 Study [Phase 2]
A-TANGO is a Phase 2 clinical trial by Yaqrit Ltd evaluating an investigational therapy for acute-on-chronic liver failure and alcoholic hep…
-
EMA approval · 2025-07-28EMA Authorised: Iqirvo (Elafibranor) — Ipsen Pharma
The EMA authorised Iqirvo (elafibranor) for liver cirrhosis and biliary diseases with conditional approval, and it has orphan medicine desig…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis [Phase 3]
Phase 3 study evaluating rifaximin soluble solid dispersion to delay hepatic encephalopathy decompensation in patients with cirrhosis, spons…